Racotumomab: A Cuban Innovation for Non-Small Cell Lung Cancer Introduction: Racotumomab and Cuba’s Leadership in Oncology Cuba, recognized worldwide for its medical innovation and commitment to global health, has developed a promising solution for one of the most aggressive types of cancer: non-small cell lung cancer (NSCLC). Racotumomab, a therapeutic vaccine, is a clear example...
